mifepristone has been researched along with Encephalopathy, Traumatic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baker, DG; Bechard, BW; Bizien, M; Flory, JD; Golier, JA; Hurley, RA; Kimbrell, T; Li, X; Reda, DJ; Yehuda, R | 1 |
| Amiresmaili, S; Amirkhosravi, L; Hashemian, M; Khaksari, M; Khorasani, P; Sanjari, M | 1 |
1 trial(s) available for mifepristone and Encephalopathy, Traumatic
| Article | Year |
|---|---|
Efficacy and Safety of Mifepristone in the Treatment of Male US Veterans With Posttraumatic Stress Disorder: A Phase 2a Randomized Clinical Trial.
Topics: Adult; Blindness; Brain Injuries, Traumatic; Female; Gallopamil; Humans; Male; Mifepristone; Stress Disorders, Post-Traumatic; United States; Veterans | 2023 |
1 other study(ies) available for mifepristone and Encephalopathy, Traumatic
| Article | Year |
|---|---|
Evaluating the neuroprotective effects of progesterone receptors on experimental traumatic brain injury: The PI3K/Akt pathway.
Topics: Animals; Brain Injuries, Traumatic; Mifepristone; Neuroprotective Agents; Phosphatidylinositol 3-Kinases; Progesterone; Proto-Oncogene Proteins c-akt; Rats; Receptors, Progesterone; Tumor Necrosis Factor-alpha | 2023 |